Detalhe da pesquisa
1.
Effects of fremanezumab in patients with chronic migraine and comorbid depression: Subgroup analysis of the randomized HALO CM study.
Headache;
61(4): 662-672, 2021 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33891348
2.
Fremanezumab for the Preventive Treatment of Chronic Migraine.
N Engl J Med;
377(22): 2113-2122, 2017 11 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29171818
3.
Effects of fremanezumab on the use of acute headache medication and associated symptoms of migraine in patients with episodic migraine.
Cephalalgia;
40(5): 470-477, 2020 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31752521
4.
Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials.
Cephalalgia;
39(1): 52-60, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29722276
5.
Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine.
Headache;
59(10): 1743-1752, 2019 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31675102
6.
The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment.
Headache;
59(3): 383-393, 2019 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30450545
7.
Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials.
Headache;
59(6): 880-890, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30977520
8.
A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects.
Cephalalgia;
38(13): 1960-1971, 2018 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29667896
9.
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial.
JAMA;
319(19): 1999-2008, 2018 05 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29800211
10.
Fremanezumab as Add-On Treatment for Patients Treated With Other Migraine Preventive Medicines.
Headache;
57(9): 1375-1384, 2017 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28862758
11.
Preventive Therapies for Chronic Migraine.
N Engl J Med;
378(8): 774, 2018 02 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29466162
12.
Pharmacokinetics and pharmacodynamics of multiple doses of BG00010, a neurotrophic factor with anti-hyperalgesic effects, in patients with sciatica.
Br J Clin Pharmacol;
82(1): 108-17, 2016 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27016000
13.
A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients.
Headache;
56(8): 1300-9, 2016 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27474357
14.
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial.
JAMA Neurol;
80(11): 1145-1154, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37812429
15.
Clinical characteristics and treatment experience of individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE): Findings from an online caregiver survey.
Seizure;
97: 50-57, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35325842
16.
Capturing seizures in clinical trials of antiseizure medications for KCNQ2-DEE.
Epilepsia Open;
6(1): 38-44, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33681646
17.
From LBR-101 to Fremanezumab for Migraine.
CNS Drugs;
32(11): 1025-1037, 2018 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30311143
18.
Humanistic and economic burden of nausea and vomiting among migraine sufferers.
J Pain Res;
10: 689-698, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28392710
19.
Subcutaneous interferon ß-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.
J Neurol Sci;
363: 33-8, 2016 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27000217
20.
TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points.
Neurology;
87(1): 41-8, 2016 Jul 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27281531